Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

TAP Block for Laparoscopic Appendicectomy in Adults

12 de junio de 2020 actualizado por: Oxford University Hospitals NHS Trust

Ultrasound Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Appendicectomy in Adults: A Double Blind Randomised Controlled Trial

Laparoscopic (key-hole) appendicectomy is a minimally invasive procedure when compared to open large bowel resection, but is still associated with a significant amount of pain and discomfort. Analgesia is commonly provided by a multi-modal technique involving varying combinations of paracetamol, Non steroidal anti-inflammatory drugs (NSAIDs), regional analgesia and oral or parenteral opioids. Opioids are associated with an increased incidence of nausea, vomiting and sedation which can complicate post-operative recovery. Different techniques of intraoperative infiltration of local anaesthetic to control postoperative pain are also being used. Their perceived benefits are thought to relate to reduced opioid consumption and therefore reduced opioid side effects.

Transversus Abdominis Plane (TAP) block is a technique which numbs the nerves carrying pain sensation from the abdominal wall and provides effective and safe analgesia with minimal systemic side effects. Their perceived benefits are thought to relate to reduced opioid consumption and therefore reduced opioid side effects. The investigators believe ultrasound guided TAP blocks will reduce pain and morphine consumption with a resultant improved patient satisfaction, a reduction in post-operative nausea and vomiting and earlier hospital discharge.

The key research question the investigators are trying to answer is whether TAP block provide better pain relief than local anaesthetic infiltration of the laparoscopic port sites. Both techniques are currently being used in the investigator's hospital.

Descripción general del estudio

Descripción detallada

Summary of Study Design: The study will be a double blind randomised controlled trial with patients undergoing laparoscopic appendicectomy randomly allocated into two groups. The study group will receive bilateral TAP blocks and the control group will receive local anaesthetic infiltration of the laparoscopic port sites

A double blind design was chosen to eliminate patient and observer bias in reporting of pain scores.

The presence of the control arm will ensure that any difference observed will be due to the effect of sensory nerve block due to the TAP block than due to the systemic effect of the injected local anaesthetic.

The null hypothesis will be that there is no difference between the groups in the amount of opioids consumed by the patients during 24 hours after the operation. The investigators chose this measurement as an objective but indirect measurement of efficacy of TAP block and pain relief thus received. Measurement of pain with various scoring methods are reliable only when concurrent reduction in consumption of pain killers are demonstrated.

Recruitment and randomisation:

All patients meeting the inclusion criteria will receive a patient information leaflet about the study during the procedure and investigators will gain informed consent during the procedure consultation. Investigators aim to recruit 288 patients with 144 patients in each group.

Informed consent will be taken the evening before, or on the morning of, surgery. Patients will then be randomly allocated into either the study group or a control group. Randomisation will occur by using computer generated random numbers using the block randomisation method. Group allocation will be kept in a consecutively numbered, opaque, sealed envelope in the controlled drugs cupboard in theatre-4/emergency theatre anaesthetic room of the John Radcliffe Hospital. Once the patient has consented, the anaesthetist will open the corresponding numbered envelope and perform bilateral TAP blocks after induction of general anaesthesia if the patient is in the study group. The surgeons will infiltrate the port sites with local anaesthetic at the end of the procedure if the patient is in the control group.

Blinding:

The study group will receive bilateral TAP blocks with 20mls 0.25% bupivacaine on each side and the skin punctures on either sides will be covered with a small plaster. Patients in the control group will receive subcutaneous infiltration of the laparoscopic port sites and specimen extraction site with equivalent amount bupivacaine at the end of the procedure and small plasters will be stuck on either flanks approximately where the skin punctures for TAP block will be made.

The assessor of pain scores and morphine doses (Recovery nurse, Ward Nursing Staff & SEU Foundation Doctor) and the patient will be blinded to group allocation.

Patient: Plasters will be stuck on flanks of all the patients, both study and control group, so that patient will not know if they have received TAP block.

Recovery nurse: During handover to recovery the anaesthetist and scrub nurse will not mention group allocation.

SEU Foundation Doctor: The foundation doctor who will be following up patients on the ward will not be present in the operating theatre, ensuring that they are blinded to the technique used.

The study duration will be from induction of anaesthesia until the patients are medically fit for discharge from hospital. No extra visits other than routinely required for the surgical procedure are expected.

Tipo de estudio

Intervencionista

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Oxford, Reino Unido, OX3 9DU
        • John Radcliffe Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

16 años y mayores (Niño, Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Participants willing and able to give informed consent for participation in the study
  • Male or Female, aged 16 years or above
  • Undergoing laparoscopic appendicectomy for a clinical diagnosis of appendicitis
  • American Society of Anaesthetists physical status (ASA) 1-3

Exclusion Criteria:

  • Opioid tolerance
  • Chronic abdominal pain
  • Allergy/Intolerance: Morphine, local anaesthetics, tramadol
  • BMI (Body Mass Index) >35 Kg/M2
  • Previous major abdominal surgery
  • High likelihood of conversion of open procedure
  • Patients unable to communicate in written and spoken English
  • Weight less than 50 kg
  • ASA > 3

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Bloque de toque
Los pacientes de este brazo recibirán un bock TAP guiado por ecografía con bupivacaína al 0,25 % 20 ml por lado o hasta un máximo de 1 mg/kg por lado y la punción cutánea se cubrirá con un pequeño apósito.
Bock TAP guiado por ecografía con Bupivacaína 0,25% 20ml por lado o hasta un máximo de 1mg/kg por lado y la punción cutánea se cubrirá con un pequeño apósito
Comparador activo: Local anaesthetic infiltration
Laparoscopic port sites will be infiltrated with a total of 20 mls 0.5% bupivacaine subcutaneously at the end of the procedure in the control group and plasters will be stuck on either side approximately where a skin puncture for tap block would be made.
Laparoscopic port sites will be infiltrated with a total of 20 mls 0.5% bupivacaine subcutaneously at the end of the procedure in the control group and plasters will be stuck on either side approximately where a skin puncture for tap block would be made.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Opioid consumption in the first 12 hours after the operation
Periodo de tiempo: 12 hours
The primary endpoint will be consumption of morphine or other opioids (including tramadol) in the first 12 hours after the operation. This will be recorded from the drug chart. Morphine equivalents include fentanyl, codeine and tramadol and will be converted into total morphine consumption using recognised conversion ratios.
12 hours

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Numerical rating pain scores at emergence, 6, 12, 24 hours postoperatively
Periodo de tiempo: 24 hours after the operation
24 hours after the operation
Time to first request for rescue analgesia
Periodo de tiempo: 24 hours after the operation
The time will be calculated from the drug chart looking up when the first dose of rescue opioid was administered
24 hours after the operation
Nausea score at emergence, 6, 12, 24 hours postoperatively
Periodo de tiempo: 24 hours after the operation
24 hours after the operation
Total length of hospital stay
Periodo de tiempo: After the operation patients will be followed up till they are medically fit to be discharged from the hospital an expected length of 1-5 days
Time will be calculated from the medical notes, when the decision that the patient is medically fit to be discharged was made
After the operation patients will be followed up till they are medically fit to be discharged from the hospital an expected length of 1-5 days
Opioid consumption at 24 hours
Periodo de tiempo: 24 hours after the operation
Consumption of morphine or other opioids (including tramadol) in the first 24 hours after the operation. This will be recorded from the drug chart. Morphine equivalents include fentanyl, codeine and tramadol and will be converted into total morphine consumption using recognised conversion ratios
24 hours after the operation

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Michael Silva, MBBS,MD,FRCS, Consultant Upper G Surgeon
  • Investigador principal: Nicholas Crabtree, MBChB,FRCA, Consultant Anaesthetist

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de agosto de 2014

Finalización primaria (Actual)

1 de agosto de 2014

Finalización del estudio (Actual)

1 de agosto de 2014

Fechas de registro del estudio

Enviado por primera vez

20 de abril de 2015

Primero enviado que cumplió con los criterios de control de calidad

14 de agosto de 2017

Publicado por primera vez (Actual)

17 de agosto de 2017

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de junio de 2020

Última actualización enviada que cumplió con los criterios de control de calidad

12 de junio de 2020

Última verificación

1 de junio de 2020

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir